Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders-Reference-Cited by-同舟云学术

Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders

Published:2016-12-08 Issue:5 Volume:28 Page:1462-1474
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Michelfelder Stefan,Parsons Juliana,Bohlender Lennard L.,Hoernstein Sebastian N.W.,Niederkrüger Holger,Busch Andreas,Krieghoff Nicola,Koch Jonas,Fode Benjamin,Schaaf Andreas,Frischmuth Thomas,Pohl Martin,Zipfel Peter F.,Reski Ralf,Decker Eva L.,Häffner Karsten

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference73 articles.

1. Recent insights into C3 glomerulopathy

2. Atypical Hemolytic–Uremic Syndrome

3. Complement system in pathogenesis of AMD: Dual player in degeneration and protection of retinal tissue.;Kawa;J Immunol Res,2014

4. Membranoproliferative Glomerulonephritis — A New Look at an Old Entity

5. Atypical hemolytic uremic syndrome

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proof of concept of a new plasma complement Factor H from waste plasma fraction;Frontiers in Immunology;2024-06-06

2. Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity;Frontiers in Immunology;2024-05-10

3. Balancing efficacy and safety of complement inhibitors;Journal of Autoimmunity;2024-05

4. The Production of Complement Inhibitor Proteins in Mammalian Cell Lines—Light at the End of the Tunnel?;Biomedicines;2024-03-14

5. The human factor H protein family – an update;Frontiers in Immunology;2024-02-12